Tim Morris | Chief Financial Officer |
Kelly DiTrapani | Vice President-Medical Affairs |
Michael Swartzburg | Vice President-Finance |
Mark Breidenbach | Oppenheimer |
Biren Amin | Jefferies |
Boris Peaker | Cowen |
Madhu Kumar | R.W. Baird |
Joe Catanzaro | Piper Jaffray |
Good afternoon, and welcome to the Iovance Biotherapeutics First Quarter 2019 Financial Results Conference Call. All participants are in a listen-only mode.
Following the formal remarks, we will open the call up for your questions. Please be advised that the call is being recorded at the Company's request.
Now I would like to turn the conference over to Tim Morris, Chief Financial Officer at Iovance.